Uniplan Investment Counsel’s Seelos Therapeutics, Inc. Common Stock SEEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-292
| Closed | -$1.34M | – | 127 |
|
|
2023
Q2 | $1.34M | Sell |
292
-1
| -0.3% | -$4.6K | 0.1% | 114 |
|
|
2023
Q1 | $778K | Sell |
293
-14
| -5% | -$37.2K | 0.05% | 117 |
|
|
2022
Q4 | $799K | Sell |
307
-340
| -53% | -$885K | 0.06% | 119 |
|
|
2022
Q3 | $2.56M | Sell |
647
-4
| -0.6% | -$15.8K | 0.2% | 93 |
|
|
2022
Q2 | $1.7M | Buy |
651
+244
| +60% | +$637K | 0.12% | 114 |
|
|
2022
Q1 | $1.31M | Buy |
407
+3
| +0.7% | +$9.66K | 0.08% | 125 |
|
|
2021
Q4 | $2.53M | Buy |
404
+1
| +0.2% | +$6.26K | 0.14% | 109 |
|
|
2021
Q3 | $3.73M | Sell |
403
-1
| -0.2% | -$9.25K | 0.23% | 79 |
|
|
2021
Q2 | $4.09M | Buy |
404
+6
| +2% | +$60.7K | 0.24% | 82 |
|
|
2021
Q1 | $7.63M | Sell |
398
-104
| -21% | -$1.99M | 0.49% | 43 |
|
|
2020
Q4 | $3.04M | Sell |
502
-27
| -5% | -$164K | 0.21% | 87 |
|
|
2020
Q3 | $1.9M | Buy |
529
+176
| +50% | +$633K | 0.13% | 102 |
|
|
2020
Q2 | $1.37M | Sell |
353
-186
| -35% | -$722K | 0.1% | 108 |
|
|
2020
Q1 | $1.01M | Buy |
539
+366
| +212% | +$689K | 0.08% | 109 |
|
|
2019
Q4 | $890K | Buy |
173
+2
| +1% | +$10.3K | 0.05% | 123 |
|
|
2019
Q3 | $604K | Sell |
171
-9
| -5% | -$31.8K | 0.04% | 120 |
|
|
2019
Q2 | $1.52M | Buy |
+180
| New | +$1.52M | 0.1% | 110 |
|